Stock Analysis on Net

DexCom Inc. (NASDAQ:DXCM)

$22.49

This company has been moved to the archive! The financial data has not been updated since October 26, 2023.

Return on Assets (ROA)
since 2005

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Calculation

DexCom Inc., ROA, long-term trends, calculation

Microsoft Excel

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$ in thousands


The financial data indicates a fluctuating trajectory in net income (loss) over the observed period. Initially, net losses were significant, with values consistently below zero from 2005 through 2018, reaching the deepest loss of -127,100 thousand US dollars in 2018. However, a notable turnaround occurred starting in 2019, as the company recorded a positive net income of 101,100 thousand US dollars, followed by continued profitability in subsequent years, with 493,600 thousand in 2020, a slight decline to 154,700 thousand in 2021, and an increase to 341,200 thousand in 2022.

Total assets exhibited a generally upward trend throughout the period. From 56,726 thousand US dollars in 2005, total assets increased substantially, albeit with some volatility, particularly between 2011 and 2014, where assets grew from approximately 120,475 thousand to 292,000 thousand US dollars. This growth accelerated markedly post-2014, culminating in assets nearing 5,391,700 thousand US dollars by 2022, suggesting significant expansion or capital investment during these years.

Return on Assets (ROA) reflects the impact of net income relative to total asset size and shows substantial volatility in the earlier years. Between 2005 and 2010, ROA was deeply negative, with the most severe drop at -124.38% in 2008. The negative returns persisted but showed gradual improvement, approaching less negative values around 2014 to 2017. Beginning in 2019, ROA shifted to positive territory, achieving a peak of 11.5% in 2020. Although it decreased to 3.18% in 2021, it recovered somewhat to 6.33% in 2022, indicating improved efficiency in asset utilization associated with the company’s shift to profitability.

Net Income (Loss)
Demonstrated large losses through 2018, followed by a significant and sustained positive turnaround from 2019 onward.
Total Assets
Displayed consistent growth over the entire timeframe with notable acceleration post-2014, signaling possible successful expansion strategies or increased capital deployment.
Return on Assets (ROA)
Mirror the net income trend, with extreme negative returns early on, gradual improvement, and eventual positive returns in later years, reflecting enhanced operational efficiency and profitability.

Overall, the data depicts a company that faced persistent financial challenges in the early period but managed to substantially improve its financial health and asset productivity in recent years. The marked increase in total assets alongside the reversal from net losses to net profits suggests a strategic shift, possibly involving investment in growth opportunities or operational restructuring, leading to enhanced returns on assets. Continued monitoring of these trends would be essential to assess the sustainability of profitability and asset growth.


Comparison to Competitors

DexCom Inc., ROA, long-term trends, comparison to competitors

Microsoft Excel

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


Comparison to Sector (Health Care Equipment & Services)

DexCom Inc., ROA, long-term trends, comparison to sector (health care equipment & services)

Microsoft Excel

Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).


Comparison to Industry (Health Care)